证券代码：301256 证券简称：华融化学 公告编号：2024-028 华融化学股份有限公司 关于聘任公司高级管理人员的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 华融化学股份有限公司（以下简称"公司）于 2024 年 4 月 18 日召开第二届 董事会第六次会议，审议通过《关于聘任公司高级管理人员的议案》，具体情况 如下： 一、聘任具体情况 1、经公司总经理提名、公司提名委员会审核，聘任万方女士为副总经理， 任期自本次董事会会议审议通过之日起至第二届董事会任期届满之日止；万方女 士原首席数字官职务继续担任。 2、经公司总经理提名、公司提名委员会审核，聘任汪云华先生为副总经理， 任期自本次董事会会议审议通过之日起至第二届董事会任期届满之日止。 3、经公司总经理提名、公司提名委员会审核，聘任罗小容女士为总经理助 理，任期自本次董事会会议审议通过之日起至第二届董事会任期届满之日止。 二、备查文件： 1. 第二届董事会第六次会议决议； 2. 第二届董事会提名委员会第三次会议决议。 附件：万方女士、汪云华先生、罗小容女士的简历 特此公告。 华融化学股份有限公 ...

证券代码：301256 证券简称：华融化学 公告编号：2024-026 华融化学股份有限公司 第二届董事会第六次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、董事会会议召开情况 华融化学股份有限公司（以下简称"公司"）第二届董事第六次会议通知于 2024 年 4 月 15 日以电子邮件的形式通知公司全体董事。会议于 2024 年 4 月 18 日 9:00 在 新希望中鼎国际 18 楼会议室以现场结合通讯表决方式召开。应出席会议的董事有 6 名，实际出席会议的董事有 6 名（其中，李建雄、张明贵、唐冲、姚宁、卜新平以通 讯表决方式出席会议）。会议由董事长邵军先生主持，公司监事、部分高级管理人员 列席了本次会议。本次会议的召集、召开和表决程序均符合《公司法》等相关法律、 行政法规、部门规章、规范性文件和《公司章程》的规定。会议表决方式为记名投票 表决。 二、董事会会议审议情况 1.审议通过《关于<2024 年第一季度报告>的议案》； 经审议，全体董事一致认为，公司编制的《2024 年第一季度报告》符合法律、行 政法规和中国证监会的规定，报告内 ...

Financial Performance - The company's operating revenue for Q1 2024 was ¥244,924,392.62, a decrease of 9.66% compared to ¥271,112,684.09 in the same period last year[10] - Net profit attributable to shareholders was ¥21,411,400.56, down 42.00% from ¥36,919,134.34 year-on-year[10] - The company reported a basic earnings per share of ¥0.04, a decrease of 50.00% from ¥0.08 in the same period last year[10] - Net profit for the current period was ¥21,411,400.56, down 42.06% from ¥36,919,134.34 in the previous period[39] - The company reported a total comprehensive income of ¥21,411,400.56, down from ¥36,919,134.34 in the previous period[39] Cash Flow - The net cash flow from operating activities was -¥43,921,036.88, a significant decline of 724.68% compared to ¥7,030,970.34 in the previous year[10] - Cash flow from operating activities showed a net outflow of ¥43,921,036.88, contrasting with a net inflow of ¥7,030,970.34 in the previous period[39] - The net cash flow from investing activities was -$208.21 million, a decrease from $295.50 million in the previous period[40] - Total cash inflow from financing activities was $47.51 million, compared to $17.61 million in the prior period[40] - The net cash flow from financing activities improved to $8.65 million from -$83.83 million year-over-year[40] - Cash and cash equivalents at the end of the period decreased to $118.77 million from $775.00 million in the previous period[40] - Cash outflow from investing activities totaled $1.12 billion, significantly higher than $361.97 million last year[40] - Cash inflow from borrowing was $40 million, an increase from $10 million in the previous period[40] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,521,677,577.49, an increase of 1.02% from ¥2,496,281,841.43 at the end of the previous year[10] - The total liabilities rose to CNY 845,768,707.27 from CNY 746,190,648.20, indicating an increase of approximately 13.3%[27] - The company's total assets reached CNY 2,521,677,577.49, up from CNY 2,496,281,841.43, representing a growth of about 1.0%[27] - The total liabilities and equity amounted to ¥2,521,677,577.49, compared to ¥2,496,281,841.43 in the previous period[29] Research and Development - Research and development expenses increased by 250.79% to ¥7,960,492.47, compared to ¥2,269,315.26 in the same period last year, reflecting a focus on chemical and digital technology[15] - Research and development expenses increased significantly to ¥7,960,492.47 from ¥2,269,315.26, marking a rise of 250.00%[30] Equity and Retained Earnings - The company’s retained earnings decreased to ¥277,861,713.54 from ¥352,450,312.98, a decline of 21.14%[29] - The total equity remained stable at CNY 480,000,000.00[27] Other Financial Metrics - The weighted average return on net assets was 1.22%, down from 2.21% in the same period last year, indicating a decline in profitability[10] - The company received government subsidies amounting to ¥65,151.61, a decrease of 96.82% from ¥2,048,217.00 in the previous year[15] - The company experienced a 1198.63% increase in other payables, amounting to ¥101,367,471.69, primarily due to declared but unpaid dividends of ¥96 million[15] Current Assets and Inventory - The total current assets increased to CNY 2,184,356,528.32 from CNY 2,160,200,755.89, reflecting a growth of approximately 1.1%[24] - Cash and cash equivalents decreased to CNY 333,368,918.30 from CNY 434,261,221.35, a decline of about 23.2%[24] - The accounts receivable increased to CNY 89,858,140.52 from CNY 72,605,819.17, showing a rise of approximately 23.7%[24] - The inventory balance increased to CNY 45,035,001.11 from CNY 43,853,814.46, reflecting a growth of about 2.7%[24] - The company's other receivables increased to CNY 3,521,268.12 from CNY 3,204,672.56, indicating a growth of approximately 9.9%[24] Borrowings - The company's short-term borrowings slightly increased to CNY 604,157,409.67 from CNY 601,584,187.47, a change of about 0.3%[27] Audit Status - The company did not undergo an audit for the first quarter report[41]

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 证券代码：301256 证券简称：华融化学 公告编号：2024-025 华融化学股份有限公司 关于为全资子公司提供担保的公告 一、担保情况概述 2024 年 3 月 7 日，华融化学股份有限公司（以下简称"公司"）第二届董事 会第五次会议审议通过了《关于为全资子公司提供担保预计的议案》；2024 年 3 月 28 日，公司 2023 年年度股东大会审议通过了该议案，同意公司为全资子公司 华融化学（成都）有限公司（以下简称"华融成都"）提供不超过 100,000.00 万 元的连带责任保证额度，为全资子公司成都华融国际贸易有限公司提供不超过 150,000.00 万元的连带责任保证额度，合计为上述全资子公司提供不超过 250,000.00 万元的连带责任保证额度（包含对子公司尚未到期的担保）。上述额 度期限自 2023 年度股东大会审议通过之日起至 2024 年度股东大会召开之日。 2024 年 4 月 3 日，公司于四川省成都市与招商银行股份有限公司（以下简称 "招商银行"）签订了《最高额不可撤销担保书》，为华融 ...

证券代码：301256 证券简称：华融化学 公告编号：2024-024 华融化学股份有限公司 2023 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 特别提示： 1．本次股东大会未出现否决议案的情形。 2．本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 1．会议召开情况 华融化学股份有限公司（以下简称"公司"）2023 年年度股东大会于 2024 年 3 月 28 日 15:30 在四川省成都市锦江区金石路 366 号新希望中鼎国际 2 号楼 18 楼会议室 召开。会议由董事长邵军先生主持。本次股东大会由董事会召集，会议采用现场表决 和网络投票相结合的方式召开。本次会议召开及表决程序符合有关法律、法规、规范 性文件和《公司章程》的规定。 2．会议出席情况 二、议案审议表决情况 本次股东大会采取现场记名投票与网络投票相结合的方式，审议以下议案并形成 决议： | 提案 | 提案名称 | 表决结果 | 同意 | | 反对 | | | 弃权 | 表决情况 | | --- | --- | --- | --- | --- ...

北京中伦（成都）律师事务所 关于华融化学股份有限公司 2023 年年度股东大会的 法律意见书 致：华融化学股份有限公司 四川省成都市高新区天府大道北段 966 号天府国际金融中心南塔 25 层-26 层 邮编：610041 25-26/F, South Tower of Tianfu International Finance Center, 966 North Tianfu Avenue, High-tech Zone, Chengdu, Sichuan 610041, P. R. China 电话/Tel : +86 28 6208 8001 传真/Fax : +86 28 6208 8111 www.zhonglun.com 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共 和国证券法》（以下简称"《证券法》"）、《上市公司股东大会规则》（以下简称 "《股东大会规则》"）、《深圳证券交易所上市公司自律监管指引第 2 号——创 业板上市公司规范运作》等法律、法规及规范性文件的规定，北京中伦（成都） 律师事务所（以下简称"中伦"或"本所"）指派律师出席了华融化学股份有限 公司（以下简称" ...

证券代码：301256 证券简称：华融化学 公告编号：2024-023 华融化学股份有限公司 关于举行 2023 年年度网上业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 华融化学股份有限公司（以下简称"公司"）已于 2024 年 3 月 8 日披露《2023 年 年度报告》。为了让广大投资者进一步了解公司的生产经营情况和发展战略，公司将 于 2024 年 3 月 28 日（星期四）16:30 至 18:00 举行 2023 年年度网上业绩说明会。本 次业绩说明会将采用网络远程的方式举行，投资者可登录全景网"投资者关系互动平 台"（https://ir.p5w.net）参与。 出席本次业绩说明会的人员有：公司总经理张炜先生，独立董事姚宁先生，财务 总监蔡晓琴女士，董事会秘书李思女士，保荐代表人桂程先生。 为充分尊重投资者，提升交流的针对性，现就公司本次业绩说明会提前向投资者 公开征集问题，广泛听取投资者的意见和建议。投资者可于 2023 年 3 月 27 日（星期 三）15:00 前访问 http://ir.p5w.net/zj/，或扫描下方 ...

Financial Performance - The company reported a total revenue of RMB 1.5 billion for the fiscal year 2023, representing a year-on-year increase of 15%[35]. - The net profit attributable to shareholders was RMB 300 million, up 20% compared to the previous year[35]. - The company's operating revenue for 2023 was CNY 1,059,324,445, a decrease of 6.67% compared to CNY 1,135,008,250 in 2022[40]. - The net profit attributable to shareholders for 2023 was CNY 138,672,921, representing an increase of 13.53% from CNY 122,148,212 in 2022[40]. - The basic earnings per share for 2023 was CNY 0.29, a 7.41% increase from CNY 0.27 in 2022[40]. - The company reported a significant increase in revenue, achieving a total of 1.5 billion yuan, representing a year-over-year growth of 20%[191]. - The gross margin improved to 35%, up from 30% in the previous year, indicating better cost management[191]. Dividend Distribution - The company plans to distribute a cash dividend of 2.0 yuan per 10 shares to all shareholders, based on a total of 480 million shares[17]. - The cash dividend distribution plan for 2023 proposes a payout of 2.0 yuan per 10 shares, amounting to 96 million yuan, which represents 100% of the distributable profit[166][167]. - The company maintains a profit distribution policy that requires a minimum of 20% of profits to be distributed as cash dividends during growth phases[167]. Market Strategy and Expansion - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share by 2025[35]. - The company is actively exploring acquisition opportunities in the specialty chemicals sector to diversify its product offerings[35]. - The company aims to optimize its operational efficiency across procurement, production, storage, and sales to enhance profitability during market downturns[128]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of 500 million yuan for potential deals[146]. - Market expansion efforts have led to a 30% increase in sales in the Southeast Asian region[147]. Research and Development - Research and development expenses amounted to RMB 100 million, accounting for 6.67% of total revenue, reflecting the company's commitment to innovation[35]. - The company is investing in new technology development, allocating 100 million yuan for R&D in the upcoming year[146]. - R&D investment amounted to ¥52,551,600.94, representing 4.96% of total revenue, a significant increase from previous years[101]. - The number of R&D personnel increased by 10.64% to 104, representing 17.25% of the total workforce[100]. Environmental and Safety Compliance - The company is committed to improving its operational safety and environmental compliance, although risks remain from potential accidents and pollution incidents[13]. - The company has successfully reduced its carbon emissions by 15% over the past year, aligning with its sustainability goals[35]. - The company has established a circular economy operation model focusing on resource development and energy utilization[65]. - The company has implemented internal control measures in compliance with the Basic Norms for Enterprise Internal Control[173]. - The company has adhered to various environmental protection laws and regulations, including the Solid Waste Pollution Prevention Law and the Environmental Protection Law, among others[177]. Supply Chain Management - The company has established a price management committee to enhance market response speed and implemented a full production and sales strategy[54]. - The digital supply chain project has reduced finished goods inventory days by over 90% and doubled the order delivery speed[79]. - The company has a dual sales model combining direct sales and distribution channels to optimize market reach[65]. - The company achieved a 2x improvement in delivery efficiency and a 9% increase in delivery quality through the implementation of the smart delivery platform[98]. Governance and Management - The company has established a governance structure that includes a shareholders' meeting, board of directors, supervisory board, and management team to protect shareholder rights[186]. - The company has a clear organizational structure that supports its operational needs without any institutional overlap with its controlling shareholders[136]. - The company has established an independent financial department with its own accounting system and management policies, ensuring financial decision-making autonomy[136]. - The company has a robust internal control system in place to ensure compliance with legal and regulatory requirements[136]. Financial Position - The total assets of the company increased to RMB 5 billion, with a debt-to-equity ratio of 0.4, indicating a stable financial position[35]. - The company's total assets increased by 12.58% to CNY 2,496,281,840 in 2023, up from CNY 2,217,204,120 in 2022[40]. - The company has not reported any significant changes in the effectiveness of its investment projects[115]. Challenges and Risks - The company acknowledges potential risks from macroeconomic fluctuations that could adversely affect product demand and sales prices[15]. - The company faces risks from intensified market competition as several domestic chemical enterprises are expected to increase potassium hydroxide production capacity in the next two years[6]. - The potassium hydroxide market faced downward pressure throughout the year, with weak demand in the first half and fluctuating prices in the second half[53]. Product Development - The company is focused on optimizing its product structure to enhance green recycling and sustainable development capabilities[10]. - The company is focusing on developing electronic-grade, photovoltaic-grade, reagent-grade, and food-grade fine potassium and chlorine products[59]. - New product lines, including eco-friendly chemical solutions, are expected to contribute an additional RMB 200 million in revenue next year[35].

2023 年 5 月 9 日，公司监事会完成换届选举，稳定了公司内部治理结构， 促进了公司的平稳发展。 华融化学股份有限公司 2023 年度监事会工作报告 华融化学股份有限公司（以下简称"公司"）监事会由 3 名成员组成，包括 2 名股东代表监事以及 1 名职工监事。2023 年公司监事会严格按照《中华人民共 和国公司法》（以下简称"《公司法》"）等关法律、法规、规范性文件及《华融化 学股份有限公司章程》（以下简称"《公司章程》"）的有关规定，切实履行监督职 责，保障股东权益、公司利益和员工的合法权益。现将公司监事会 2023 年工作 情况汇报如下： 一、 2023 年度监事会会议情况 2、检查公司财务情况。2023 年度，监事会对公司财务状况和财务制度进行 了监督和检查，认为公司财务制度健全、内部控制制度完善，财务体系运行规范、 财务状况良好，2023 年度的财务报告客观、真实地反映了公司的财务状况和经 营成果。 3、关联交易情况。监事会对 2023 年度发生的关联交易进行核查后认为，公 司发生的关联交易遵循了公平、公开、公正的原则，定价公平合理，履行了必要 的决策程序，不存在损害公司和中小股东利益的情形。 ...

华融化学股份有限公司董事会审计委员会 对会计师事务所 2023 年度履行监督职责情况报告 根据《中华人民共和国公司法》《上市公司治理准则》《国有企业、上市公司选聘会计 师事务所管理办法》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规 范运作》等法律法规和《华融化学股份有限公司章程》及《董事会审计委员会工作制度》《会 计师事务所选聘制度》的规定，董事会审计委员会本着勤勉尽责的原则，恪尽职守，认真履 职，现将对四川华信（集团）会计师事务所（特殊普通合伙）（以下简称"四川华信"）2023 年度履行监督职责情况汇报如下： 一、会计师事务所基本情况 （一）基本信息 2、投资者保护能力 1、基本信息 名称：四川华信（集团）会计师事务所（特殊普通合伙） 成立日期：初始成立于 1988 年 6 月，2013 年 11 月 27 日改制为特殊普通合伙企业。 组织形式：特殊普通合伙 注册地址：泸州市江阳中路 28 号楼三单元 2 号；总部办公地址：成都市武侯区洗面桥 街 18 号金茂礼都南 28 楼； 首席合伙人：李武林。 四川华信自 1997 年开始一直从事证券服务业务。 截至 2023 年 12 月 31 ...